Evidence map›Paper›PMID 38332935›Full record

ArticleLancet regional health. Americas2024

Cervical cancer screening coverage in the Americas region: a synthetic analysis.

Ginna Fernández-Deaza, Beatriz Serrano, Esther Roura, Juan Sebastián Castillo, María Caicedo-Martínez, Laia Bruni, Raúl Murillo

Abstract read
In one paragraph

Article in Lancet regional health. Americas, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Geographical inequities in cervical cancer screening coverage in Bolivia: a spatial nationwide ecological study.Revista panamericana de salud publica = Pan American journal of public health · 2025
    Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ginna Fernández-DeazaCentro Javeriano de Oncología, Hospital Universitario San Ignacio, Bogotá, Colombia.
Beatriz SerranoCancer Epidemiology Research Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.
Esther RouraCancer Epidemiology Research Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.
Juan Sebastián CastilloFacultad de Medicina, Pontificia Universidad Javeriana, Bogotá, Colombia.
María Caicedo-MartínezCentro Javeriano de Oncología, Hospital Universitario San Ignacio, Bogotá, Colombia.
Laia BruniCancer Epidemiology Research Program, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain.
Raúl MurilloCentro Javeriano de Oncología, Hospital Universitario San Ignacio, Bogotá, Colombia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The Americas region has the lowest (North America) and the second highest (Latin America and Caribbean) cervical cancer (CC) mortality worldwide. The lack of reliable data on screening coverage in the region hinders proper monitoring of the World Health Organization (WHO) CC elimination initiative. Methods: For this synthetic analysis, we searched data on CC screening coverage from official sources and national health surveys, supplemented with a formal WHO country consultation. Context data were obtained from official sources (income, health expenditure, inequality-adjusted human development index -IHDI-, universal health coverage, CC incidence/mortality). Country age-specific coverages for 2019 by screening interval were computed. Missing data were imputed through a multi-step algorithm. Beta-regression and Poisson-regression models were used to analyse associations between context variables, screening coverage, and CC mortality. Findings: We included data from 37 countries in the Americas. Data on coverage of HPV testing was scarce, and for many countries only Pap-smear coverage data was available. Overall, 78%, 34%, 60%, and 67% of women aged 25-65 years have been screened ever in their lifetime, and in the previous year, 3 years, and 5 years, respectively. By sub-region, 3-year coverage ranges from 48% (South America) to 72% (North America). Twenty-four countries showed screening coverage below 70%. Income and health system type were associated with screening coverage, but coverage was not associated with CC mortality. Interpretation: In the Americas region 35.1% and 56.8% of countries report 3-year and 5-year coverage over 70%, respectively. Inequalities remain a major challenge for screening programs in the region. The elimination campaign should reinforce the transition to HPV testing and strengthen surveillance systems. Funding: Instituto de Salud Carlos III, European Regional Development Fund, Secretariat for Universities and Research of the Department of Business and Knowledge of the Government of Catalonia, and Horizon 2020.

Indexed as

AmericasEarly detection of cancerMass screeningUterine cervical neoplasms

Identifiers

PMID38332935
PMCPMC10850953

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.